LifeCycle Pharma Appoints Dr. Karin Hamberg as Executive Vice President of Research and Development

HORSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX:LCP) announced today the appointment of Dr. Karin Hamberg as Executive Vice President for Research and Development effective June 1, 2008.

MORE ON THIS TOPIC